This HTML5 document contains 186 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46764831
rdf:type
wikibase:Item
schema:description
επιστημονικό άρθρο vetenskaplig artikel article científic наукова стаття, опублікована в жовтні 2013 artigo científico ৪ অক্টোবর ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2013年学术文章 teaduslik artikkel vedecký článok wissenschaftlicher Artikel article scientific naučni članak articolo scientifico บทความทางวิทยาศาสตร์ 2013年学术文章 bài báo khoa học 2013年の論文 artykuł naukowy научни чланак مقالة علمية نشرت في 4 أكتوبر 2013 2013 թվականի հոկտեմբերի 4-ին հրատարակված գիտական հոդված artikel ilmiah 2013年学术文章 2013年學術文章 artículu científicu 2013년 논문 videnskabelig artikel scientific article published on 4 October 2013 научная статья artikulong pang-agham 2013年学术文章 articol științific мақолаи илмӣ 2013年學術文章 artículo científico publicado en 2013 bilimsel makale tieteellinen artikkeli scientific article published on 4 October 2013 wetenschappelijk artikel vědecký článek artigo científico научни чланак 2013年學術文章 სამეცნიერო სტატია vitskapeleg artikkel מאמר מדעי tudományos cikk artigo científico 2013年學術文章 2013年学术文章 2013 nî lūn-bûn scienca artikolo vitenskapelig artikkel scientific article published on 4 October 2013 научна статия artikull shkencor 2013年學術文章 2013年学术文章 article scientifique
p:P577
wds:Q46764831-0625A33A-49FE-4B2A-A3C8-DE8186A3991F
wdt:P577
2013-10-04T00:00:00Z
p:P2860
wds:Q46764831-E8691861-E761-4E30-8613-4BCCD8F60948 wds:Q46764831-F870115C-A3ED-4A49-B89E-AF9D830CEDFB wds:Q46764831-4C49F658-F5FD-430A-ABA8-94CDB877EDBE wds:Q46764831-29EE56BB-C650-4AD3-94FB-6FB1D06622FD wds:Q46764831-3674C97A-271C-4650-BFD7-87AE47CE6C56 wds:Q46764831-36AE0C83-5EE7-4F6D-9F94-04393E616E50 wds:Q46764831-10E2A92D-8B3C-4637-B16C-F67DEB2BAA9D wds:Q46764831-11610F89-3002-4BBA-A4B3-CEFF448CA52C wds:Q46764831-22F27CF6-39C9-4813-8BC5-C0C140E84D19 wds:Q46764831-0B6D1FDE-1B3C-41F0-805F-28C38868A4AF wds:Q46764831-0F43F984-9F1C-42FD-88DA-D24E4FBF4980 wds:Q46764831-1098BA0A-4566-4250-A700-8C5AF8E8C04F wds:Q46764831-8DB7D65F-084E-409E-AF28-1C6D62051EF6 wds:Q46764831-900BC8DA-195E-4F61-991C-4714D1506F8C wds:Q46764831-959BCC34-48AE-4F78-8FA8-245618630450 wds:Q46764831-77F74CE5-DC3A-4223-BDC4-06965ABAC5AB wds:Q46764831-78BB5F0E-F996-4089-9755-B15F7AB71842 wds:Q46764831-6ED601BC-5969-4EEE-B30D-2627E72A5B8D wds:Q46764831-50820A2D-647E-498C-8E1D-126180EB18A6 wds:Q46764831-532D9C3A-FDE2-4B09-BBF8-CC6D10B26EAC wds:Q46764831-539D595D-C85A-40E6-AC1A-478C34AABBFD wds:Q46764831-68004068-39C3-4C68-9BBA-90E14040C806 wds:Q46764831-C07D9B0A-CF44-4748-B0DA-40B8C24F34A8 wds:Q46764831-D98F3E16-9A15-46E8-B64E-38CA35AC06C2 wds:Q46764831-9D85BA12-6488-4826-BBCD-78F3DE085DCA wds:Q46764831-9E05E1BC-F7E6-447A-B490-3CD71F55BB52 wds:Q46764831-A2754BE7-9D8E-47EF-9BFC-4B2AC5E13774 wds:Q46764831-968779E8-FD81-4409-BA6F-55E519D6F8DF wds:Q46764831-9929C9E1-BABE-4747-B1DE-F6A2183C7DFE
wdt:P2860
wd:Q47951353 wd:Q83154089 wd:Q27851691 wd:Q27824766 wd:Q33827808 wd:Q44648834 wd:Q83137320 wd:Q73494751 wd:Q52893849 wd:Q27824847 wd:Q27860693 wd:Q36042217 wd:Q28282744 wd:Q27851705 wd:Q24630844 wd:Q35710898 wd:Q27851763 wd:Q27851549 wd:Q40321992 wd:Q37380452 wd:Q52890142 wd:Q28254919 wd:Q27824846 wd:Q37087832 wd:Q29616112 wd:Q43180234 wd:Q56622251 wd:Q77093352 wd:Q77438388
p:P2093
wds:Q46764831-2CBB4D4D-A19A-4E48-AD4B-FFF664FDC9E7 wds:Q46764831-4D2BA427-8250-45A9-99F7-093770F7BA2C wds:Q46764831-09E0E0D9-ECEA-4814-8F43-5AC1F78C6781 wds:Q46764831-21D42266-1A26-4D61-A34D-DF666925B773 wds:Q46764831-04DEF7A7-B02B-4DB0-BEBB-F14755310360 wds:Q46764831-FC986E2D-D6DF-42E3-91A6-89EDA8A7DEBE wds:Q46764831-E3935389-A0EF-41C7-AA9E-68AEF2136A5A wds:Q46764831-DF79086C-67C7-48DC-946E-482ADA1104BF wds:Q46764831-E085FB3E-0780-42FE-B431-B19A763A49D4 wds:Q46764831-FB090A9E-88DC-43C5-8E54-8EE3E459C0C1 wds:Q46764831-EC7A43B0-C54B-415A-A3EB-19DE706FEDD9 wds:Q46764831-A9076F76-FB37-4101-8927-6B10B1C01804 wds:Q46764831-A9492211-A368-4B7E-B4B5-05E01D12CFA2 wds:Q46764831-B6834166-6476-4FDC-B73C-100D6A1138D6 wds:Q46764831-9710B2AB-3283-4E2D-8F06-EE0683BC96B5 wds:Q46764831-994618B9-9A62-4523-BC7D-C900AC06EE82 wds:Q46764831-80F5D291-F228-42C2-93E0-3726F42F42F9 wds:Q46764831-71C399E4-9BF4-455D-B158-CC98BCD53C30
wdt:P2093
Richard G Margolese Louis Baez-Diaz Hanna Bandos Norman Wolmark Shakir Sarwar Adam M Brufsky Charles E Geyer Harry D Bear William B Farrar Joseph P Costantino Catherine A Azar Henry R Shibata André Robidoux Priya Rastogi Soonmyung Paik Gong Tang Louis Fehrenbacher James N Atkins
rdfs:label
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
skos:prefLabel
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
schema:name
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
p:P50
wds:Q46764831-A88EBBA3-760B-4154-AD32-45560A4A3470 wds:Q46764831-689E0FC6-DA9D-40AD-9033-78E70BCA8F43
wdt:P50
wd:Q96147434 wd:Q37839297
p:P1476
wds:Q46764831-E8458099-ADB3-4080-A9BE-0BE8E1C0A01F
wdt:P1476
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
p:P304
wds:Q46764831-6804CF26-E778-417B-A4AD-8645C50086EF
wdt:P304
1183-1192
p:P31
wds:Q46764831-A5E6F6C2-1B98-486D-93F6-EB11252D4073
wdt:P31
wd:Q13442814
p:P921
wds:Q46764831-85A3F971-FE2E-4C0A-B525-1467EFE35D87
wdt:P921
wd:Q42824827
p:P698
wds:Q46764831-B9B2182A-500E-448E-9FC6-E134559602A3
wdtn:P698
n10:24095300
wdt:P698
24095300
p:P1433
wds:Q46764831-49219A69-7FC4-426F-BCBB-3EAE5E81D791
wdt:P1433
wd:Q13747613
p:P433
wds:Q46764831-3A9CA2CE-741B-4FF6-8F3C-D6D18DA69697
p:P478
wds:Q46764831-75B31346-8ED8-43A8-A910-576387580B21
wdt:P433
12
wdt:P478
14
p:P356
wds:Q46764831-963731CC-3503-4677-BB4A-CAA08B66B863
wdtn:P356
n12:S1470-2045(13)70411-X
wdt:P356
10.1016/S1470-2045(13)70411-X